Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 31, Issue Suppl 1
4CPS-158 Relapsed/refractory multiple myeloma and new therapeutic options: experience in a phase 1 clinical trials unit
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Section 4: Clinical pharmacy services
4CPS-158 Relapsed/refractory multiple myeloma and new therapeutic options: experience in a phase 1 clinical trials unit
Free
Online download statistics by month:
Online download statistics by month: March 2024 to November 2024
Abstract
Full
Pdf
Mar 2024
31
0
16
Apr 2024
40
0
7
May 2024
16
0
0
Jun 2024
10
0
1
Jul 2024
8
0
4
Aug 2024
6
0
3
Sep 2024
8
0
1
Oct 2024
9
0
1
Nov 2024
12
0
3
Total
140
0
36
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via EAHP
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF